The role of biotransformation in chemical-induced liver injury

Insights

Drug metabolism significantly contributes to chemical-induced liver injury by forming reactive metabolites. Understanding factors influencing their formation and binding is crucial for predicting and preventing liver damage from various drugs.

Area of Science:

  • Toxicology
  • Pharmacology
  • Drug Metabolism

Background:

  • Chemical-induced liver injury is a significant clinical concern.
  • Drug metabolism pathways play a critical role in the toxicity of xenobiotics.
  • Reactive metabolites are implicated as key mediators of drug-induced liver damage.

Purpose of the Study:

  • To review the role of drug metabolism in chemical-induced liver injury.
  • To discuss parameters for studying the formation of chemically reactive metabolites.
  • To emphasize factors altering reactive metabolite formation and covalent binding.

Main Methods:

  • Literature review focusing on chemical toxicology and drug metabolism.
  • Discussion of experimental methodologies for assessing reactive metabolite formation.
  • Analysis of factors influencing covalent binding of reactive metabolites.

Main Results:

  • Drug metabolism can generate reactive intermediates capable of causing cellular damage.
  • Factors such as enzyme induction/inhibition and genetic polymorphisms affect reactive metabolite levels.
  • Covalent binding of reactive metabolites to cellular macromolecules is a critical step in toxicity.

Conclusions:

  • Drug metabolism is a central mechanism in chemical-induced liver injury.
  • Understanding the modulation of reactive metabolite formation is key to mitigating drug toxicity.
  • Specific examples like acetaminophen and bromobenzene illustrate these toxicological principles.

Related Concept Videos

Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
Drug Biotransformation: Overview01:28

Drug Biotransformation: Overview

Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Phase II Reactions: Miscellaneous Conjugation Reactions01:19

Phase II Reactions: Miscellaneous Conjugation Reactions

Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs01:21

Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in determining the metabolic...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...